Skip to content

Comparative Study of Two Different Endoscopic Treatment Modalities for Rectal Neuroendocrine Tumors

Comparative Study of Two Different Endoscopic Treatment Modalities for Rectal Neuroendocrine Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127844
Enrollment
Unknown
Registered
2026-07-08
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal neuroendocrine neoplasms (R-NENs) are tumors derived from neuroendocrine cells of the rectal mucosa. Although most of these tumors grow slowly, they carry risks of metastasis and recurrence.

Interventions

ESD-PMR group:None
ESD group:None

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Cases of rectal neuroendocrine neoplasms treated by endoscopy; 2.Lesion diameter less than 2 cm; 3.No regional lymph node metastasis or distant metastasis suggested by preoperative auxiliary examinations; 4.Endoscopic procedures: ESD or ESD-PMR;

Exclusion criteria

Exclusion criteria: 1.Patients with other concomitant conditions deemed ineligible by the researchers; 2.Patients with other concomitant diseases judged unsuitable for inclusion by researchers; 3.Patients or their families who refuse enrollment;

Design outcomes

Primary

MeasureTime frame
Positive resection margin rate;

Secondary

MeasureTime frame
En bloc resection rate;

Countries

China

Contacts

Public ContactYang Dong

The First Hospital of Jilin University

yang_dong@jlu.edu.cn+86 431 88782721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026